Initiating Basal Insulin Therapy in Type 2 Diabetes: Practical Steps to Optimize Glycemic Control-Reference-Cited by-同舟云学术

Initiating Basal Insulin Therapy in Type 2 Diabetes: Practical Steps to Optimize Glycemic Control

Published:2013-09 Issue:9 Volume:126 Page:S21-S27
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Philis-Tsimikas Athena

Publisher

Elsevier BV

Subject

General Medicine

Reference54 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030;Shaw;Diabetes Res Clin Pract,2010

2. World Health Organization. Diabetes fact sheet 312 (2011). Available at: http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed April 22, 2013.

3. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

4. Glycemic response to newly initiated diabetes therapies;Karter;Am J Manag Care,2007

5. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes;Diabetology & Metabolic Syndrome;2024-07-09

2. Evaluating the efficacy and safety of weekly Insulin Icodec vs. Daily Insulin Glargine in type 2 Diabetes Mellitus: a systematic review and meta-analysis;Journal of Diabetes & Metabolic Disorders;2024-04-23

3. L & Vous : enquête nationale pour évaluer l’utilisation de l’insuline basale chez les patients diabétiques de type 2 en Algérie;Médecine des Maladies Métaboliques;2024-03

4. LIVE INDIA: Effectiveness of Gla-100 in a Post hoc Pooled Analysis of FINE ASIA and GOAL Registries;Diabetes Therapy;2023-10-04

5. Optimal dosing of gliclazide—A model‐based approach;Basic & Clinical Pharmacology & Toxicology;2023-04-22